{"id":"W4362456136","doi":"10.1158/1078-0432.ccr-22-3207","title":"SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Melanoma; Adjuvant therapy; Adjuvant; Radiation therapy; Surgery; Oncology; Gastroenterology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001457692,0.001426485,0.001256288,0.0002903177,0.0002909911,0.0009370445,0.0007182265,0.001050655,0.004155084],"category_scores_gemma":[0.0010931,0.0003917967,0.001548234,0.0001787997,0.0008701286,0.00077674,0.0005068823,0.00187389,0.000760447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006172712,"about_ca_system_score_gemma":0.001169655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004953728,"about_ca_topic_score_gemma":0.001316985,"domain_scores_codex":[0.9996118,0.0002056625,0.00002163243,0.00006599535,0.00003522089,0.00005960012],"domain_scores_gemma":[0.9993727,0.0001089967,0.0001684886,0.00005103721,0.00003040525,0.0002684558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9603944,0.005890533,0.001885894,0.0007428046,0.001107507,0.00008457097,0.0000972798,0.0007621386,0.006418983,0.0002313812,0.001529724,0.02085473],"study_design_scores_gemma":[0.8790416,0.1122377,0.003884581,0.00006774545,0.0006481666,0.00009902848,0.00004033778,0.0009985002,0.001101947,0.0002409785,0.001620053,0.00001948962],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992257,0.00291272,0.0003461533,0.000787758,0.0003272358,0.001128815,0.0005951355,0.00008297845,0.001562251],"genre_scores_gemma":[0.9884235,0.001571689,0.001149646,0.000763301,0.0004238305,0.002459594,0.001213633,0.00002295364,0.00397179],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004155084,"threshold_uncertainty_score":0.0139001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2984597270626484,"score_gpt":0.5228688469826615,"score_spread":0.2244091199200131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}